Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This is a combination dietary supplement containing omega-3 fatty acids (primarily eicosapentaenoic acid, EPA), vitamin E, vitamin A, copper, and selenium. The formulation is designed to provide both anti-inflammatory and antioxidant effects. Omega-3 fatty acids are known for their cardiovascular benefits and ability to reduce inflammation by modulating the production of pro-inflammatory mediators. Vitamin E and vitamin A act as antioxidants that help protect cells from oxidative stress. Copper and selenium are essential trace minerals involved in various enzymatic processes; both contribute to antioxidant defense systems—copper as a cofactor for superoxide dismutase (SOD) and selenium as an essential component of glutathione peroxidase (GPx). This specific combination has been studied as an add-on supplement in patients with rheumatoid arthritis to improve nutritional status, enhance antioxidant defenses, lower triglycerides, and potentially reduce disease activity[1][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on omega-3 fatty acids + vitamin e + vitamin a + copper + selenium.